Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+](c)/ROS-pathway in human endothelial cells
Publication year
2022Source
Biomedicine & Pharmacotherapy, 146, (2022), article 112515ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Physiology
Neurology
Cardiology
Journal title
Biomedicine & Pharmacotherapy
Volume
vol. 146
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [229134]
- Electronic publications [111496]
- Faculty of Medical Sciences [87758]
- Open Access publications [80319]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.